Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chatbot and teen mentors improve sexual health in Kenya's slums?

NCT ID NCT07587281

Knowledge-focused Sponsor: Pacific Institute for Research and Evaluation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

This study tests a mobile chatbot called AskDoki, which provides age-appropriate sexual health information via WhatsApp, along with trained youth peer leaders (Digital Champions) who help teens access and use the program. About 610 adolescents aged 15-19 living in urban informal settlements in Kenya will take part. Researchers will compare changes in knowledge, attitudes, and intentions between communities that get the program and those that don't, to see if this approach can help reduce teenage pregnancy and STIs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chatbot providing comprehensive sexuality education plus youth peer facilitators
What this could lead to
If it works, this could point toward a scalable way to improve sexual health knowledge and reduce risky behaviors among teens in underserved communities.
What could go wrong
This is an early-stage study measuring changes in knowledge and attitudes, not actual health outcomes. The results may not apply to other settings, and the program may not change real-world behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 610 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 19 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Adolescent participants Inclusion criteria: * age 15-19 * residing in one of the informal settlements participating in the study * not planning to relocate for 18 months * not currently married or living as married * comprehension of informed consent * willing to provide assent/consent Exclusion criteria: * Age 14 and younger * Age 20 and older * Married/living as married * Planning to relocate within 18 months * Not residing in one of the informal settlements participating in the study * Unable to comprehend informed consent * Unwilling to provide assent/consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mhealth intervention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sexually transmitted disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mhealth intervention

Contacts and locations

Locations

  • Amref Health Africa in Kenya

    Nairobi, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.